Sentinel Oncology
Business Services · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
181 Cambridge Science Park, Milton Road,...Phone Number
+44 1223653209Website
www.sentineloncology.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Sentinel Oncology
Sentinel Oncology, founded in 2005 in Cambridge, UK, specializes in discovering innovative cancer therapies, particularly for primary brain tumors and systemic tumors that spread to the brain. The company focuses on the development and commercialization of highly selective and targeted oncology candidate drugs, with a pipeline that includes three late-stage preclinical programs set to enter phase 1 clinical trials in 2023. Their mission is to improve the survival and quality of life for patients facing cancer and other diseases with high unmet medical needs. Sentinel Oncology collaborates with leading scientific experts and industry partners to advance their research and therapeutic offerings.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sentinel Oncology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Sentinel Oncology has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Sentinel Oncology has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Sentinel Oncology launches new products
Congratulate Masked Content for being promoted to Masked Content at Sentinel Oncology
Earning: See what the market has to say on Sentinel Oncology recently announced quarterly report
Click to see if Sentinel Oncology had a recent Job posting/layoffs
Check out if Sentinel Oncology is spiking on competitors!
Sentinel Oncology, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Sentinel Oncology
Find more new buyers
Compare Similar Companies to Sentinel Oncology
Compare insights from companies similar to Sentinel Oncology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Sentinel Oncology
<$5M
1-10
Private
<$5M
2005
N/A
Company Profile Activity
Activity Insights
Sentinel Oncology is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Sentinel Oncology is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Sentinel Oncology.
Sentinel Oncology financials insights
Gather financial insights about Sentinel Oncology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Other Financing Round
$915K
Sentinel Oncology Tech Stack
A closer look at the technologies used by Sentinel Oncology
Sentinel Oncology News & Media
PharmaEngine, Inc. and Sentinel Oncology Limited Enter into an Exclusive Collaboration and License Agreement for SOL-578, a Chk1 inhibitor
TAIPEI, Dec. 4, 2020 /PRNewswire/ -- PharmaEngine, Inc. (TWO: 4162) announced today that it has entered into a Collaboration and License Agreement with UK-based Sentinel Oncology Limited for advancing the new drug development of SOL-578, a Checkpoint Kinase 1 (Chk1) inhibitor, under which...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sentinel Oncology
Sign Up For FreeTo access detailed company insights
Sentinel Oncology, founded in 2005 in Cambridge, UK, specializes in discovering innovative cancer therapies, particularly for primary brain tumors and systemic tumors that spread to the brain. The company focuses on the development and commercialization of highly selective and targeted oncology candidate drugs, with a pipeline that includes three l... Read More
